Advances in Radiation Treatment for Brain Tumors
A special issue of Current Oncology (ISSN 1718-7729). This special issue belongs to the section "Neuro-Oncology".
Deadline for manuscript submissions: 15 December 2025 | Viewed by 464
Special Issue Editor
Special Issue Information
Dear Colleagues,
While significant technological advancements have become the norm in radiation oncology, these have not always been accompanied by observable improvement in patient outcomes and have required significant resource-intense approaches to clinical implementation and testing to justify rising costs. Areas of ongoing clinical need can be addressed in a multifactorial fashion via several critical need areas comprising: (1) biologically personalized treatment planning including integration of multi-omic data to tailor dose distribution to tumor biology and adjustment of treatment fields based on tumor response; (2) advanced AI driven automation for efficiency and precision including auto contouring, auto segmentation and AI based quality assurance; (3) the combination of AI with advanced treatment modalities including FLASH and heavy ion radiotherapy; (4) leveraging radiotherapy immune modulation and (5) actively focusing on big data and federated learning initiatives that incorporate radiation therapy dosimetry data and train AI algorithms across multiple institutions including large-scale AI models analyzing clinical, imaging and molecular data to improve prognostication and decision support.
Dr. Andra Krauze
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- personalized treatment
- artificial intelligence
- automation
- segmentation
- adaptive treatment
- immune modulation
- fed-erated learning
- multi-omics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
